AIMC Topic: gag Gene Products, Human Immunodeficiency Virus

Clear Filters Showing 1 to 1 of 1 articles

Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens.

HIV research & clinical practice Jan 30, 2020
To understand the pathogenesis of low level viraemia (LLV) in HIV-infected patients on boosted protease inhibitors (PI/b), we enrolled 34 subjects with a median HIV-RNA 79 copies/mL and followed them for 15 months. Samples for next generation sequenc...
Humans Female Adult Male Middle Aged HIV Infections Viral Load Mutation Viremia Anti-Retroviral Agents Antiretroviral Therapy, Highly Active HIV-1 High-Throughput Nucleotide Sequencing United Kingdom Drug Resistance, Multiple, Viral HIV Protease HIV Protease Inhibitors gag Gene Products, Human Immunodeficiency Virus
View on PubMed DOI
Popular Topics
Recent Journals